Kathleen Valiasek - Amyris CFO

AMRSDelisted Stock  USD 0.04  0  8.64%   

CFO

Ms. Kathleen Valiasek serves as Chief Business Officer of the Company. Ms. Valiasek served as Chief Executive Officer of a finance and strategic consulting firm she founded in 1994, in which capacity she provided financial and strategic consulting services to several companies. Ms. Valiasek experience encompasses serving with fastgrowing companies including those among the Fortune 500 and across the life sciences, tech, retail, telecommunications, real estate, and healthcare sectors. Prior to joining Amyris, Valiasek was Founder and Chief Executive Officer of Lenox Group, Inc., a finance and strategic consulting firm where she worked closely with the senior management teams of private and public companies including such organizations as Kaiser Permanente, Inc., Albertsons, Inc. and Cytokinetics, Inc. Prior to that, she served in key VC, real estate development and accounting roles since 2019.
Tenure 5 years
Phone510 450 0761
Webhttps://amyris.com
Valiasek resultsdriven background includes specific areas of expertise in finance, SEC reporting, strategic planning, debt and equity financing, business development, and mergers and acquisitions. Valiasek holds a Bachelor of Business Administration degree in accounting from the University of Massachusetts, Amherst, MA

Kathleen Valiasek Latest Insider Activity

Tracking and analyzing the buying and selling activities of Kathleen Valiasek against Amyris stock is an integral part of due diligence when investing in Amyris. Kathleen Valiasek insider activity provides valuable insight into whether Amyris is net buyers or sellers over its current business cycle. Note, Amyris insiders must abide by specific rules, including filing SEC forms every time they buy or sell Amyris'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

Amyris Management Efficiency

The company has return on total asset (ROA) of (0.464) % which means that it has lost $0.464 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (5.3208) %, meaning that it created substantial loss on money invested by shareholders. Amyris' management efficiency ratios could be used to measure how well Amyris manages its routine affairs as well as how well it operates its assets and liabilities.
The company currently holds 981.55 M in liabilities with Debt to Equity (D/E) ratio of 1.62, which is about average as compared to similar companies. Amyris Inc has a current ratio of 0.86, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Amyris until it has trouble settling it off, either with new capital or with free cash flow. So, Amyris' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Amyris Inc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Amyris to invest in growth at high rates of return. When we think about Amyris' use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 4 records

CFO Age

Gordon SangsterCodexis
65
Susan BarnesPacific Biosciences of
64
Mike WillisGevo Inc
44
Todd WaltzAemetis
63
Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty, and flavors and fragrance markets in Europe, North America, Asia, and South America. Amyris, Inc. was incorporated in 2003 and is headquartered in Emeryville, California. Amyris operates under Specialty Chemicals classification in the United States and is traded on NASDAQ Exchange. It employs 980 people. Amyris Inc (AMRS) is traded on NASDAQ Exchange in USA and employs 1,598 people.

Management Performance

Amyris Inc Leadership Team

Elected by the shareholders, the Amyris' board of directors comprises two types of representatives: Amyris inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Amyris. The board's role is to monitor Amyris' management team and ensure that shareholders' interests are well served. Amyris' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Amyris' outside directors are responsible for providing unbiased perspectives on the board's policies.
Raymond Williams, Independent Director
Karen Weaver, Principal Accounting Officer, Vice President - Finance
Peter Denardo, Director of Investor Relations and Corporate Communications
Lisa Qi, Director
Patrick Yang, Director
Philippe Boisseau, Director
Caroline Hadfield, Pres Aprinnova
Margaret Georgiadis, Director
Kathleen Valiasek, CFO
Jonathan Wolter, Interim CFO
Anthony Hughes, Chief Accounting Officer
Karen Rohde, Chief Human Resources Officer
Tina Maloney, Chief Accounting Officer
Christophe Vuillez, Director
Nicole Kelsey, Chief Sec
Oreste Fieschi, President of Sweeteners and Ingredients
Raffi Asadorian, CFO
Carole Piwnica, Independent Director
Eduardo Alvarez, Chief Officer
James McCann, Director
Hermanus Kieftenbeld, CFO Officer
Christine Ofori, Chief Officer
John Melo, CEO and President and Director
Philip Eykerman, Director
Abdullah Thani, Independent Director
Christoph Goppelsroeder, Director
Charles Kraft, VP Devel
Neil Williams, Independent Director
Fernando Reinach, Independent Director
Abraham Klaeijsen, Director
Elizabeth CPA, Chief Controller
Geoffrey Duyk, Independent Director
Nicholas Khadder, Sr. VP, General Counsel and Corporate Secretary
Joel Cherry, President of RandD
Frank Kung, Director
Chris Jaenike, Interim General Counsel
Jim Iacoponi, VP Ingredients
John Doerr, Independent Director
Steven Mills, Director

Amyris Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Amyris a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Amyris in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Amyris' short interest history, or implied volatility extrapolated from Amyris options trading.

Pair Trading with Amyris

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amyris position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amyris will appreciate offsetting losses from the drop in the long position's value.

Moving against Amyris Stock

  0.94XOM Exxon Mobil Corp Earnings Call This WeekPairCorr
  0.92CHKEZ Chesapeake EnergyPairCorr
  0.91CHKEL Chesapeake EnergyPairCorr
  0.86AA Alcoa Corp Financial Report 17th of July 2024 PairCorr
  0.86BAC Bank of America Buyout TrendPairCorr
The ability to find closely correlated positions to Amyris could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Amyris when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Amyris - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Amyris Inc to buy it.
The correlation of Amyris is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Amyris moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Amyris Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Amyris can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Other Consideration for investing in Amyris Stock

If you are still planning to invest in Amyris Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Amyris' history and understand the potential risks before investing.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities